Catawba River Capital Boosts Holdings in Transcat, Inc. (NASDAQ:TRNS)

Catawba River Capital lifted its stake in shares of Transcat, Inc. (NASDAQ:TRNS) by 2.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 67,300 shares of the scientific and technical instruments company’s stock after buying an additional 1,473 shares during the period. Transcat comprises about 4.2% of Catawba River Capital’s holdings, making the stock its 11th largest position. Catawba River Capital’s holdings in Transcat were worth $7,116,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. US Bancorp DE grew its holdings in Transcat by 15.6% in the third quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock worth $187,000 after purchasing an additional 209 shares during the period. Ellsworth Advisors LLC grew its stake in shares of Transcat by 4.4% in the 3rd quarter. Ellsworth Advisors LLC now owns 5,041 shares of the scientific and technical instruments company’s stock worth $609,000 after buying an additional 213 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in Transcat by 8.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,312 shares of the scientific and technical instruments company’s stock valued at $396,000 after buying an additional 263 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in Transcat by 8.8% in the third quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company’s stock worth $557,000 after acquiring an additional 373 shares in the last quarter. Finally, nVerses Capital LLC purchased a new stake in shares of Transcat in the third quarter worth $60,000. 98.34% of the stock is owned by institutional investors.

Insider Transactions at Transcat

In other news, Director Craig D. Cairns bought 1,200 shares of the stock in a transaction on Friday, January 31st. The shares were bought at an average price of $77.02 per share, with a total value of $92,424.00. Following the completion of the acquisition, the director now owns 1,910 shares in the company, valued at $147,108.20. The trade was a 169.01 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 2.30% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on TRNS. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. Oppenheimer downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Northland Securities reissued a “market perform” rating and set a $85.00 price target (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. HC Wainwright lowered their price objective on Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Finally, Craig Hallum increased their target price on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $111.50.

Transcat Stock Performance

Shares of NASDAQ TRNS opened at $77.88 on Tuesday. The firm’s 50-day moving average price is $99.76 and its 200-day moving average price is $111.19. Transcat, Inc. has a 52-week low of $73.37 and a 52-week high of $147.12. The company has a market cap of $725.06 million, a PE ratio of 42.10 and a beta of 0.67. The company has a quick ratio of 3.00, a current ratio of 2.42 and a debt-to-equity ratio of 0.14.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same period in the previous year, the company earned $0.56 EPS. As a group, analysts anticipate that Transcat, Inc. will post 2.3 EPS for the current year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.